Tumor-intrinsic YTHDF1 drives immune evasion and can be targeted to restore antitumor immunity
Feb. 1, 2023
N6-methyladenosine (m6A) is the most common endogenous modification in eukaryotic RNAs. Researchers are starting to understand the impact of changes in m6A levels on cancer mechanisms, including immune evasion.